Key NAEVR Messages

  • Eye and vision disease is now at epidemic proportions and represents a major public health problem.

  • The economic and societal cost of eye disease and vision impairment is $68 billion annually and growing, and the annual amount of federally funded research spent on it is less than one percent of that number.

  • Adequately funding the NEI is a cost-effective investment, since the treatments and therapies derived from its basic and translational research can delay, save and prevent expenditures to the Medicare and Medicaid programs.

  • Past NEI funding has successfully resulted in key basic and translational research findings that culminate in treatments and therapies that restore vision and prevent the onset of disease.